{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:36:42Z","timestamp":1780393002478,"version":"3.54.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ijantimicag.2011.05.010","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T13:34:52Z","timestamp":1311600892000},"page":"465-473","source":"Crossref","is-referenced-by-count":23,"title":["Posaconazole for the treatment of mucormycosis"],"prefix":"10.1016","volume":"38","author":[{"given":"D.A.","family":"Enoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Aliyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Karas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0010","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mycres.2007.03.004","article-title":"A higher-level phylogenetic classification of the Fungi","volume":"111","author":"Hibbett","year":"2007","journal-title":"Mycol Res"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2011.05.010_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1469-0691.2009.02987.x","article-title":"Lipid formulations of amphotericin B as first-line treatment of zygomycosis","volume":"15","author":"Petrikkos","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0025","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1086\/523576","article-title":"Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent","volume":"45","author":"Nagappan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0030","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/AAC.00747-06","article-title":"Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae","volume":"50","author":"Chau","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jac\/dki140","article-title":"Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes","volume":"55","author":"Gil-Lamaignere","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0040","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JCM.42.3.1224-1227.2004","article-title":"Comparison of the semisolid agar antifungal susceptibility test with the NCCLS M38-P broth microdilution test for screening of filamentous fungi","volume":"42","author":"Kuzucu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JCM.44.2.553-560.2006","article-title":"Rapid susceptibility testing of medically important zygomycetes by XTT assay","volume":"44","author":"Antachopoulos","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0050","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/JCM.01187-06","article-title":"Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B","volume":"44","author":"Espinel-Ingroff","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0055","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.01539-06","article-title":"In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest","volume":"51","author":"Torres-Narbona","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0060","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/JCM.00134-07","article-title":"Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin","volume":"45","author":"Espinel-Ingroff","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0065","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JCM.01883-07","article-title":"Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole","volume":"46","author":"Espinel-Ingroff","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1006970503053","article-title":"In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi","volume":"141","author":"Marco","year":"1998","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0075","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0080","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0090","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0095","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0105","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0110","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1128\/AAC.00662-08","article-title":"Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"52","author":"Lass-Fl\u00f6rl","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.diagmicrobio.2008.12.013","article-title":"A comparison of the fungicidal activity of amphotericin B and posaconazole against zygomycetes in vitro","volume":"63","author":"Krishnan-Natesan","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0924-8579(01)00363-6","article-title":"In vitro antifungal activity of posaconazole against various pathogenic fungi","volume":"18","author":"Uchida","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0125","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","article-title":"Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi","volume":"50","author":"Cuenca-Estrella","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.00969-06","article-title":"Posaconazole prophylaxis in experimental systemic zygomycosis","volume":"51","author":"Barchiesi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13693780801975576","article-title":"Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus","volume":"46","author":"Arikan","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0140","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.01467-08","article-title":"Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers","volume":"53","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0145","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.01463-09","article-title":"Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice","volume":"54","author":"Rodr\u00edguez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0150","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/jac\/dkq276","article-title":"In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility","volume":"65","author":"Spreghini","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0155","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13693780802562969","article-title":"In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi","volume":"47","author":"Gonz\u00e1lez","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0165","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.02030-08","article-title":"Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole","volume":"47","author":"Khan","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0170","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1128\/AAC.00786-10","article-title":"In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella","volume":"54","author":"Pastor","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0175","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JCM.01420-10","article-title":"Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern","volume":"48","author":"Chakrabarti","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0180","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.46.7.2310-2312.2002","article-title":"In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0185","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/AAC.47.11.3647-3650.2003","article-title":"Activity of posaconazole in treatment of experimental disseminated zygomycosis","volume":"47","author":"Dannaoui","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0190","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.01124-08","article-title":"Posaconazole mono- or combination therapy for treatment of murine zygomycosis","volume":"53","author":"Ibrahim","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0195","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPH.0b013e3181c2bdce","article-title":"Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature","volume":"32","author":"Garbino","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0205","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/375075","article-title":"Mucormycosis (zygomycosis) in a heart\u2013kidney transplant recipient: recovery after posaconazole therapy","volume":"36","author":"Tob\u00f3n","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0210","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1086\/504328","article-title":"Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections","volume":"42","author":"Raad","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0215","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case\u2013control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0220","first-page":"773","article-title":"Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia","volume":"3","author":"Leather","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.05.010_bib0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1439-0507.2006.01301.x","article-title":"Posaconazole for treatment of refractory invasive fungal disease","volume":"49","author":"Notheis","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajo.2006.02.053","article-title":"Periorbital zygomycosis (mucormycosis) treated with posaconazole","volume":"142","author":"Rutar","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0235","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/pbc.20572","article-title":"Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant","volume":"47","author":"Gilman","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1099\/jmm.0.47069-0","article-title":"Rhizopus microsporus var. rhizopodiformis sinus\u2013orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course","volume":"56","author":"Stark","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1439-0507.2008.01595.x","article-title":"Successful therapy with ABLC, surgery and posaconazole for Rhizopus microsporus var. rhizopodiformis liver eumycetoma in a child with acute leukaemia","volume":"52","author":"Sedlacek","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0250","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1399-3062.2008.00324.x","article-title":"Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature","volume":"10","author":"Page","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0255","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1439-0507.2008.01499.x","article-title":"Posaconazole as first line treatment for disseminated zygomycosis","volume":"51","author":"Peel","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1399-3062.2009.00484.x","article-title":"Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection","volume":"12","author":"Lebeau","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0265","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1097\/MPH.0b013e3181e622bf","article-title":"Intra-abdominal Rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy","volume":"32","author":"Ting","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0270","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2007.05.178","article-title":"Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae","volume":"55","author":"Kok","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1439-0507.2008.01536.x","article-title":"Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report","volume":"52","author":"Vyzantiadis","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0280","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1017\/S0022215110000678","article-title":"Use of posaconazole in the treatment of infective rhinocerebral mucormycosis","volume":"124","author":"Kulendra","year":"2010","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1399-3062.2009.00480.x","article-title":"Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation","volume":"12","author":"Leithauser","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0290","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/INF.0b013e3181dc8352","article-title":"Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease","volume":"29","author":"Wildenbeest","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0295","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3109\/13693781003694796","article-title":"A noninvasive renal fungus ball caused by Rhizopus\u2013a previously unreported manifestation of zygomycosis","volume":"48","author":"Palacio-Bedoya","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0300","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.TP.0000164140.26123.E6","article-title":"Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy","volume":"80","author":"Brugi\u00e8re","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0305","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.jinf.2004.11.002","article-title":"Absidia posttraumatic infection: successful treatment with posaconazole","volume":"51","author":"Garbino","year":"2005","journal-title":"J Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.05.010_bib0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1439-0507.2006.01300.x","article-title":"Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia","volume":"49","author":"S\u00f6rensen","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0315","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/pbc.21918","article-title":"Treatment of intestinal and hepatic mucormycosis in an immunocompromized child","volume":"52","author":"L\u00fcer","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0320","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/13693780802595746","article-title":"An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections","volume":"47","author":"Almaslamani","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPH.0b013e3181ca0dcf","article-title":"Successful triple combination therapy of disseminated Absidia corymbifera infection in an adolescent with osteosarcoma","volume":"32","author":"Roux","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0330","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1399-543X.2005.00118.x","article-title":"Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature","volume":"6","author":"Simmons","year":"2005","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0335","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archopht.125.6.848","article-title":"Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole","volume":"125","author":"Gelston","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0340","first-page":"68","article-title":"Successful treatment and limb salvage of Mucor necrotizing fasciitis after kidney transplantation with posaconazole","volume":"66","author":"Harada","year":"2007","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0345","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1592\/phco.27.2.290","article-title":"Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature","volume":"27","author":"Page","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0350","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.ajkd.2007.09.026","article-title":"Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B","volume":"51","author":"Sedlacek","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0355","first-page":"657","article-title":"Patient with abdominal pain-concealing gastrointestinal mucormycosis","volume":"5","author":"Azhar","year":"2009","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0360","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/sur.2008.049","article-title":"Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease","volume":"10","author":"Mezhir","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2011.05.010_bib0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1439-0507.2006.01299.x","article-title":"Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia","volume":"49","author":"Rickerts","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0370","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JCM.00305-09","article-title":"Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia","volume":"47","author":"Abuali","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0375","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/000313480907501221","article-title":"Successful treatment of ascending aortic graft and valve endocarditis after debulking splenectomy for invasive aspergillosis and Mucor","volume":"75","author":"Nebel","year":"2009","journal-title":"Am Surg"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1439-0507.2009.01708.x","article-title":"Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy","volume":"53","author":"Busca","year":"2010","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0385","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/JCM.00014-07","article-title":"Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes","volume":"45","author":"Ferguson","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0390","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0395","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.athoracsur.2005.09.043","article-title":"Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole","volume":"82","author":"Paul","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0400","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/IOP.0b013e318070855b","article-title":"Rhinocerebral mucormycosis with perineural spread","volume":"23","author":"Margo","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0405","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/bmt.2008.199","article-title":"Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation","volume":"42","author":"Schlemmer","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0410","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbmt.2009.04.007","article-title":"Fatal Rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature","volume":"15","author":"Lekakis","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0415","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1399-3062.2009.00479.x","article-title":"Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation","volume":"12","author":"Mousset","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0425","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.00240-09","article-title":"Posaconazole therapeutic drug monitoring: a reference laboratory experience","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0430","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.50.2.658-666.2006","article-title":"Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection","volume":"50","author":"Ullmann","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0435","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1592\/phco.27.12.1627","article-title":"Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease","volume":"27","author":"Krishna","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0440","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/QCO.0b013e3283184611","article-title":"Therapeutic drug monitoring for triazoles","volume":"21","author":"Hope","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0445","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.00454-06","article-title":"Posaconazole plasma concentrations in juvenile patients with invasive fungal infection","volume":"51","author":"Krishna","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0450","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/AAC.01396-09","article-title":"Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients","volume":"54","author":"Conte","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0455","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-200544020-00006","article-title":"Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations","volume":"44","author":"Ezzet","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0460","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1592\/phco.27.6.825","article-title":"Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus","volume":"27","author":"Sansone-Parsons","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0465","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/AAC.00184-09","article-title":"In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes","volume":"53","author":"Dannaoui","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0470","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkq020","article-title":"In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes","volume":"65","author":"Narreddy","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0475","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00595-07","article-title":"Synergistic effect of posaconazole and caspofungin against clinical zygomycetes","volume":"51","author":"Guembe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0480","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0091270009360982","article-title":"Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin","volume":"51","author":"Krishna","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0485","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00492-08","article-title":"Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro","volume":"52","author":"Perkhofer","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.05.010_bib0490","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jac\/dkn005","article-title":"In vitro activities of combinations of amphotericin B, posaconazole and four other agents against Rhizopus","volume":"61","author":"Ballester","year":"2008","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T18:23:17Z","timestamp":1638123797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911002512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0924857911002512"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.05.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}